SIBN Earnings Date: Nov 2, 2026 (Estimated) — SI-BONE, Inc.
NASDAQ · Healthcare · Medical Devices
Updated
When is SIBN's next earnings date?
SI-BONE, Inc. (SIBN) is expected to report Q3 2026 earnings on Monday, November 2, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.13 on revenue of $55.3M.
How did SIBN do in its last earnings report?
In its most recent report on Aug 3, 2026 (Q2 2026), SI-BONE, Inc. posted EPS of -$0.09 versus the -$0.15 estimate, a beat of 40.0%. Revenue was $56.0M against a $55.2M estimate. The stock's 1-day post-earnings move was -0.1%.
How much does SIBN stock move after earnings?
SIBN beat EPS estimates in 8 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 10.5% (up or down) in the day after earnings.
About SI-BONE, Inc.
SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring. Beyond iFuse, the company offers advanced iterations like iFuse-3D. This titanium implant retains the distinctive triangular cross-section of the original iFuse but incorporates a proprietary 3D-printed porous surface and a fenestrated design. Another offering is iFuse-TORQ, a series of 3D-printed threaded implants. These are specifically engineered for treating pelvic fractures and facilitating minimally invasive sacroiliac joint fusion procedures. SI-BONE distributes its products primarily through a dedicated direct sales force, complemented by a network of independent distributors. Established in 2008, the company maintains its corporate headquarters in Santa Clara, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-03 | Q2 2026 | -0.15 | -0.09 | +40.00% | $56.0M | ✅ Beat | -0.05% | +2.11% | +2.55% |
| 2026-05-11 | Q1 2026 | -0.19 | -0.10 | +47.37% | $52.6M | ✅ Beat | +19.72% | +27.13% | +32.39% |
| 2026-02-23 | Q4 2025 | -0.13 | -0.04 | +69.23% | $56.4M | ✅ Beat | -2.11% | +0.51% | -15.69% |
| 2025-11-10 | Q3 2025 | -0.16 | -0.11 | +31.25% | $48.7M | ✅ Beat | +16.20% | +14.29% | +19.83% |
| 2025-02-24 | Q4 2024 | -0.13 | -0.11 | +15.38% | $49.0M | ✅ Beat | +5.55% | +0.57% | -15.97% |
| 2024-11-12 | Q3 2024 | -0.24 | -0.16 | +33.33% | $40.3M | ✅ Beat | -15.93% | -21.18% | -12.92% |
| 2024-02-26 | Q4 2023 | -0.28 | -0.27 | +3.57% | $38.9M | ✅ Beat | -13.53% | -13.44% | -25.51% |
| 2023-08-07 | Q2 2023 | -0.41 | -0.30 | +26.83% | $33.3M | ✅ Beat | -11.17% | -9.17% | -5.67% |
Showing last 8 quarters.
Revenue by segment & region
By region
Q2 FY26 · $56.0M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 95.0% | $53.2M | +14.7% | $84.7M | $44.8M | $46.4M | $46.4M |
| Non-US | 5.0% | $2.8M | +25.9% | $4.2M | $2.5M | $2.2M | $2.3M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.